528 related articles for article (PubMed ID: 33304284)
1. How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis.
Panariello F; Cellini L; Speciani M; De Ronchi D; Atti AR
Front Psychiatry; 2020; 11():582345. PubMed ID: 33304284
[TBL] [Abstract][Full Text] [Related]
2. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
[TBL] [Abstract][Full Text] [Related]
3. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
[TBL] [Abstract][Full Text] [Related]
4. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
5. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
6. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
8. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).
Payus AO; Liew Sat Lin C; Mohd Noh M; Jeffree MS; Ali RA
Bosn J Basic Med Sci; 2020 Aug; 20(3):283-292. PubMed ID: 32530389
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
11. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.
Devaux CA; Rolain JM; Raoult D
J Microbiol Immunol Infect; 2020 Jun; 53(3):425-435. PubMed ID: 32414646
[TBL] [Abstract][Full Text] [Related]
12. Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019.
Liu MY; Zheng B; Zhang Y; Li JP
Chronic Dis Transl Med; 2020 Jun; 6(2):98-105. PubMed ID: 32550040
[TBL] [Abstract][Full Text] [Related]
13. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
Ermis U; Rust MI; Bungenberg J; Costa A; Dreher M; Balfanz P; Marx G; Wiesmann M; Reetz K; Tauber SC; Schulz JB
Neurol Res Pract; 2021 Mar; 3(1):17. PubMed ID: 33712089
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection.
Pacheco-Herrero M; Soto-Rojas LO; Harrington CR; Flores-Martinez YM; Villegas-Rojas MM; León-Aguilar AM; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Corniel-Taveras CN; Dominguez-García JJ; Blanco-Alvarez VM; Luna-Muñoz J
Front Neurol; 2021; 12():660087. PubMed ID: 33912129
[TBL] [Abstract][Full Text] [Related]
15. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
16. Kawasaki-like disease in children with COVID-19: A hypothesis.
Amirfakhryan H
Med Hypotheses; 2020 Oct; 143():110117. PubMed ID: 32721809
[TBL] [Abstract][Full Text] [Related]
17. Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease.
Monteonofrio L; Florio MC; AlGhatrif M; Lakatta EG; Capogrossi MC
Vasc Biol; 2021; 3(1):R1-R14. PubMed ID: 33537555
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
19. The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?
Abassi Z; Knaney Y; Karram T; Heyman SN
Front Immunol; 2020; 11():1312. PubMed ID: 32582222
[TBL] [Abstract][Full Text] [Related]
20. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.
Li Y; Zhou W; Yang L; You R
Pharmacol Res; 2020 Jul; 157():104833. PubMed ID: 32302706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
